Kabra Drugs Stock Screener | Share Price & Fundamental Analysis
KABRADG
Pharmaceuticals
Share Price BSE
₹30.51
▲
0.60 (2.01%)
Track Kabra Drugs share price live with TickJournal's free stock screener.
Analyze Kabra Drugs share price history trends and compare 52-week high low
levels.
Calculate KABRADG stock fair value using fundamental analysis and view live share price charts.
Determine Kabra Drugs share intrinsic value and compare it with current KABRADG share price.
Record your Kabra Drugs trades in TickJournal's free trading journal and track your portfolio performance.
Kabra Drugs Market Cap
₹72.44 Cr.
KABRADG P/E Ratio (TTM)
16.07
EPS (TTM)
₹-0.99
Dividend Yield
-
Debt to Equity
0.08
KABRADG 52 Week High
₹34.67
Kabra Drugs 52 Week Low
₹11.08
Operating Margin
3.00%
Profit Margin
6.90%
KABRADG Revenue (TTM)
₹58.00
EBITDA
₹5.00
Net Income
₹4.00
Total Assets
₹25.00
Total Equity
₹25.00
Kabra Drugs Share Price History - Stock Screener Chart
Screen KABRADG historical share price movements with interactive charts. Analyze price trends and patterns.
Kabra Drugs Company Profile - Fundamental Screener
Screen Kabra Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for KABRADG shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE323K01017
Kabra Drugs Balance Sheet Screener
Screen KABRADG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 25 | 5 | 1 | 1 | 1 | 1 | 2 | 2 | 6 | 9 |
| Current Assets | 25 | 5 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 6 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 25 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Share Capital | 24 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 1 | -6 | -5 | -5 | -5 | -4 | -4 | -4 | -2 | -2 |
Kabra Drugs Income Statement Screener - Profit & Revenue Analysis
Screen Kabra Drugs income statement and profit fundamentals.
Analyze KABRADG quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Kabra Drugs share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 10 | 8 |
| Expenses | 54 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 9 | 8 |
| EBITDA | 5 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 1 | 0 |
| Operating Profit % | 3.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -57.00% | 6.00% | 5.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 5 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 4 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| EPS | 1.90 | -0.99 | -1.68 | -0.77 | -0.42 | -0.41 | -0.14 | -0.38 | -5.37 | 0.30 | 0.06 | 0.16 |
Kabra Drugs Cash Flow Screener - Liquidity Fundamentals
Screen KABRADG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Financing Activities | 23 | 3 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Net Cash Flow | 19 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Kabra Drugs Shareholding Pattern Screener
See Kabra Drugs shareholding pattern with promoter, FII, and DII holdings.
Check Kabra Drugs promoter holding and ownership changes for KABRADG on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 95.94% | 95.61% | 95.00% | 91.43% | 95.73% | 95.85% | 96.19% | 96.12% |
| Other Holding | 4.06% | 4.39% | 5.00% | 8.57% | 4.27% | 4.15% | 3.81% | 3.88% |
| Shareholder Count | 7,435 | 7,449 | 8,098 | 8,862 | 7,364 | 7,336 | 7,367 | 7,343 |
Kabra Drugs Share Dividend Screener - Share Yield Analysis
Check Kabra Drugs dividend history with payout and yield data.
View Kabra Drugs dividend details including ex-dates and amounts for KABRADG stock.
Kabra Drugs Stock Index Membership
See which indices include Kabra Drugs stock.
Check KABRADG index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Kabra Drugs Market Events Screener - Corporate Actions
Get Kabra Drugs corporate actions including splits, bonuses, and buybacks.
Check Kabra Drugs stock events that may affect KABRADG share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.53% | ||
| Change Of Name | NA | 0.00% | ||
| Annual General Meeting | NA | 4.94% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 11.26% |
| 2025-12-26 | 2025-12-26 | Extraordinary General Meeting | NA | -0.91% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 7.48% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 1.97% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 4.97% |
| 2025-01-02 | 2025-01-02 | Extraordinary General Meeting | NA | 4.90% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 4.92% |
| 2024-02-17 | 2024-02-17 | Extraordinary General Meeting | NA | 10.13% |
Kabra Drugs Competitors Screener - Peer Comparison
Screen KABRADG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 39.09 | 54,729 | 9.71% | 10,980 | 55.50 |
| Divis Laboratories | 170,126 | 69.29 | 9,712 | 18.67% | 2,191 | 57.58 |
| Torrent Pharmaceuticals | 146,659 | 65.55 | 11,539 | 6.99% | 1,911 | 65.06 |
| Cipla | 108,904 | 24.19 | 28,410 | 7.12% | 5,291 | 47.64 |
| Dr Reddys Laboratories | 107,359 | 19.93 | 33,741 | 16.73% | 5,725 | 55.60 |
| Lupin | 105,151 | 22.74 | 22,910 | 13.74% | 3,306 | 66.87 |
| Mankind Pharma | 92,782 | 52.20 | 12,744 | 20.90% | 2,007 | 63.52 |
| Zydus Life Science | 92,745 | 18.78 | 23,511 | 18.55% | 4,615 | 55.01 |
| Aurobindo Pharma | 70,881 | 20.37 | 32,346 | 9.43% | 3,484 | 58.41 |
| Alkem Laboratories | 67,429 | 28.38 | 13,458 | 3.70% | 2,216 | 51.36 |
Kabra Drugs Company Announcements - News Screener
Screen KABRADG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-08 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7 2026 | View |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St December 2025. | View |
| 2026-02-13 | Financial Results For The Quarter Ended 31St December 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 | View |
| 2026-02-13 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2026-02-06 | Board Meeting Intimation for Intimation Of Board Meeting | View |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-01 | Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 01St January 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-27 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-12-26 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-12-22 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-03 | Submission Of Notice Of Extra Ordinary General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-28 | Appointment Of Secretarial Auditor Of The Company | View |
| 2025-11-28 | Resignation Of Secretarial Auditor Of The Company | View |
| 2025-11-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th November 2025 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-20 | Board Meeting Intimation for Intimation Of Board Meeting | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Financial Results For The Quarter Ended 30 Th September 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 | View |